|
| No equal opportunity for leukemia initiating cells |
|
https://doi.org/10.18632/oncotarget.26454
Tom Verbiest, Simon Bouffler, and Christophe Badie
|
| 37078-37079 |
|
| A comparative pharmacokinetic study of PARP inhibitors demonstrates favorable properties for niraparib efficacy in preclinical tumor models |
|
https://doi.org/10.18632/oncotarget.26354
Kaiming Sun, Keith Mikule, Zebin Wang, Grace Poon, Aparajitha Vaidyanathan, Gillian Smith, Zhi-Yi Zhang, Jeffrey Hanke, Sridhar Ramaswamy, and Jing Wang
|
| 37080-37096 |
|
| Oncogenic transgelin2 is differentially regulated in isocitrate dehydrogenase wildtype vs mutant gliomas |
|
https://doi.org/10.18632/oncotarget.26365
Sasha J. Beyer, Erica H. Bell, Joseph P. McElroy, Jessica L. Fleming, Tiantian Cui, Aline Becker, Emily Bassett, Benjamin Johnson, Pooja Gulati, Ilinca Popp, Ori Staszewski, Marco Prinz, Anca L. Grosu, Saikh Jaharul Haque, and Arnab Chakravarti
|
| 37097-37111 |
|
| Detection of histone H3 K27M mutation and posttranslational modifications in pediatric diffuse midline glioma via tissue immunohistochemistry informs diagnosis and clinical outcomes |
|
https://doi.org/10.18632/oncotarget.26430
Tina Huang, Roxanna Garcia, Jin Qi, Rishi Lulla, Craig Horbinski, Amir Behdad, Nitin Wadhwani, Ali Shilatifard, Charles James, and Amanda M. Saratsis
|
| 37112-37124 |
|
| Predicting clinically significant prostate cancer using DCEMRI habitat descriptors |
|
https://doi.org/10.18632/oncotarget.26437
N. Andres Parra, Hong Lu, Qian Li, Radka Stoyanova, Alan Pollack, Sanoj Punnen, Jung Choi, Mahmoud Abdalah, Christopher Lopez, Kenneth Gage, Jong Y. Park, Yamoah Kosj, Julio M. Pow-Sang, Robert J. Gillies, and Yoganand Balagurunathan
|
| 37125-37136 |
|
| The molecular mechanism of action of methylene quinuclidinone and its effects on the structure of p53 mutants |
|
https://doi.org/10.18632/oncotarget.26440
Sara Ibrahim Omar, and Jack Tuszynski
|
| 37137-37156 |
|
| STAT1 deficiency supports PD1/PDL1 signaling resulting in dysfunctional TNFα mediated immune responses in a model of NSCLC |
|
https://doi.org/10.18632/oncotarget.26441
Juliane Friedrich, Lisanne Heim, Denis I. Trufa, Horia Sirbu, Ralf J. Rieker, Mircea T. Chiriac, and Susetta Finotto
|
| 37157-37172 |
|
| Chronic lymphocytic leukemia cells from ibrutinib treated patients are sensitive to Axl receptor tyrosine kinase inhibitor therapy |
|
https://doi.org/10.18632/oncotarget.26444
Sutapa Sinha, Justin C. Boysen, Kari G. Chaffee, Brian F. Kabat, Susan L. Slager, Sameer A. Parikh, Charla R. Secreto, Tim Call, Tait D. Shanafelt, Jose F. Leis, Steven L. Warner, David J. Bearss, Asish K. Ghosh, and Neil E. Kay
|
| 37173-37184 |
|
| Microenvironmentderived ADAM28 prevents cancer dissemination |
|
https://doi.org/10.18632/oncotarget.26449
Catherine Gérard, Céline Hubeau, Oriane Carnet, Marine Bellefroid, Nor Eddine Sounni, Silvia Blacher, Guillaume Bendavid, Markus Moser, Reinhard Fässler, Agnès Noel, Didier Cataldo, and Natacha Rocks
|
| 37185-37199 |
|
| Payload of TDM1 binds to cell surface cytoskeletonassociated protein 5 to mediate cytotoxicity of hepatocytes |
|
https://doi.org/10.18632/oncotarget.26461
Yukinori Endo, Kazuyo Takeda, Nishant Mohan, Yi Shen, Jiangsong Jiang, David Rotstein, and Wen Jin Wu
|
| 37200-37215 |
|
| Ybox binding protein YBX1 and its correlated genes as biomarkers for poor outcomes in patients with breast cancer |
|
https://doi.org/10.18632/oncotarget.26469
Tomohiro Shibata, Eriko Tokunaga, Satoshi Hattori, Kosuke Watari, Yuichi Murakami, Nami Yamashita, Eiji Oki, Junji Itou, Masakazu Toi, Yoshihiko Maehara, Michihiko Kuwano, and Mayumi Ono
|
| 37216-37228 |
|
| Extracellular vesicles: biomarkers and regulators of vascular function during extracorporeal circulation |
|
https://doi.org/10.18632/oncotarget.26433
Mark J. McVey, and Wolfgang M. Kuebler
|
| 37229-37251 |
|
| Cell penetrating peptides in preclinical and clinical cancer diagnosis and therapy |
|
https://doi.org/10.18632/oncotarget.26442
Prem Prakash Tripathi, Hamed Arami, Ivneet Banga, Jalaj Gupta, and Sonu Gandhi
|
| 37252-37267 |
|
| Correction: Verteporfin inhibits gastric cancer cell growth by suppressing adhesion molecule FAT1 |
|
https://doi.org/10.18632/oncotarget.26488
Myoung-Hee Kang, Gi Seok Jeong, Duane T. Smoot, Hassan Ashktorab, Chang Mo Hwang, Byung Sik Kim, Hee Sung Kim, and Yun-Yong Park
|
| 37268-37268 |
|
| Correction: Oncogenomics of cMyc transgenic mice reveal novel regulators of extracellular signaling angiogenesis and invasion with clinical significance for human lung adenocarcinoma |
|
https://doi.org/10.18632/oncotarget.26489
Yari Ciribilli, and Jürgen Borlak
|
| 37269-37269 |
